Moderna rallies 12% after Q3 revenue beats estimates



Shares of Moderna Inc. jumped during Thursday’s premarket trade after the biotechnology giant posted a better-than-expected revenue for the third quarter of fiscal 2024, driven by hotter COVID-19 vacc…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento